Giora Kornblau

Giora Kornblau is the Chief Technology Officer (CTO) at Rapid Medical, a company that develops advanced endovascular devices for neurovascular treatments.12 As CTO, Kornblau plays a key role in the company's technological innovations and product development.

Professional Background

Kornblau has a significant background in medical technology and device development. At Rapid Medical, he has been instrumental in the creation of innovative neurovascular treatment solutions. He was involved in the development of DRIVEWIRE 24, a breakthrough deflectable access platform that recently received FDA clearance and has been used in initial neurovascular cases in the USA.12

Expertise and Contributions

Kornblau's expertise lies in developing technologies that enhance clinical possibilities and patient safety in neurovascular procedures. He has stated that their design goal with DRIVEWIRE was "to bring new levels of access and control to the interventional suite while improving best-in-class guidewires".2 This reflects his focus on creating tools that allow physicians to respond in real-time to patient anatomy and tailor their approach for better procedural outcomes.

Educational Background

According to available information, Giora Kornblau attended the Air Force Academy from 1993 to 1995.5 This educational background likely contributes to his technical expertise and problem-solving skills in his current role.

Additional Interests

Outside of his professional work, Kornblau appears to have an interest in robotics. He has been associated with a robotics team called Orbit 1690 from Israel, which won a prestigious robotics tournament called Chezy Champs in 2021.4

Giora Kornblau's LinkedIn profile can be found under the username "giorakornblau", where he shares updates about Rapid Medical's achievements and innovations in the field of neurovascular treatments.3